Pondering the Promyelocytic Leukemia Protein (PML) Puzzle: Possible Functions for PML Nuclear Bodies

REFERENCES

• Abid, M. R., Y. Li, C. Anthony, and A. De Benedetti. 1999. Translational regulation of ribonucleotide reductase by eukaryotic initiation factor 4E links protein synthesis to the control of DNA replication. J. Biol. Chem. 274: 35991–35998.
   PubMed Web of Science ®Google Scholar
• Alcalay, M., L. Tomassoni, E. Colombo, S. Stoldt, F. Grignani, M. Fagioli, L. Szekely, K. Helin, and P. G. Pelicci. 1998. The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein. Mol. Cell. Biol. 18: 1084–1093.
   PubMedGoogle Scholar
• Ascoli, C. A., and G. G. Maul. 1991. Identification of a novel nuclear domain. J. Cell Biol. 112: 785–795.
   PubMed Web of Science ®Google Scholar
• Bell, P., L. J. Montaner, and G. G. Maul. 2001. Accumulation and intranuclear distribution of unintegrated human immunodeficiency virus type 1 DNA. J. Virol. 75: 7683–7691.
   PubMedGoogle Scholar
• Benoit, G. R., J. H. Tong, Z. Balajthy, and M. Lanotte. 2001. Exploring (novel) gene expression during retinoid-induced maturation and cell death of acute promyelocytic leukemia. Semin. Hematol. 38: 71–85.
   PubMedGoogle Scholar
• Boddy, M. N., K. Howe, L. D. Etkin, E. Solomon, and P. S. Freemont. 1996. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene 13: 971–982.
   PubMed Web of Science ®Google Scholar
• Boisvert, F. M., M. J. Hendzel, and D. P. Bazett-Jones. 2000. Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J. Cell Biol. 148: 283–292.
   PubMed Web of Science ®Google Scholar
• Borden, K. L. B. 2000. RING domains: master builders of molecular scaffolds? J. Mol. Biol. 295: 1103–1112.
   PubMedGoogle Scholar
• Borden, K. L. B., M. N. Boddy, J. Lally, N. J. O'Reilly, S. Martin, K. Howe, E. Solomon, and P. S. Freemont. 1995. The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML. EMBO J. 14: 1532–1541.
   PubMed Web of Science ®Google Scholar
• Borden, K. L. B., E. J. Campbell Dwyer, G. W. Carlile, M. Djavani, and M. S. Salvato. 1998. Two RING finger proteins, the oncoprotein PML and the arenavirus Z protein, colocalize with the nuclear fraction of the ribosomal P proteins. J. Virol. 72: 3819–3826.
   PubMed Web of Science ®Google Scholar
• Borden, K. L. B., E. J. Campbell Dwyer, and M. S. Salvato. 1998. An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J. Virol. 72: 758–766.
   PubMed Web of Science ®Google Scholar
• Borden, K. L. B., E. J. Campbell Dwyer, and M. S. Salvato. 1997. The promyelocytic leukemia protein PML has a pro-apoptotic activity mediated through its RING domain. FEBS Lett. 418: 30–34.
   PubMedGoogle Scholar
• Borden, K. L. B., J. M. Lally, S. R. Martin, N. J. O'Reilly, E. Solomon, and P. S. Freemont. 1996. In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML. Proc. Natl. Acad. Sci. USA 93: 1601–1606.
   PubMedGoogle Scholar
• Campbell Dwyer, E. J., H. Lai, R. C. MacDonald, M. S. Salvato, and K. L. B. Borden. 2000. The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner. J. Virol. 74: 3293–3300.
   PubMed Web of Science ®Google Scholar
• Carlile, G. W., W. G. Tatton, and K. L. B. Borden. 1998. Demonstration of a RNA-dependent nuclear interaction between the promyelocytic leukaemia protein and glyceraldehyde-3-phosphate dehydrogenase. Biochem. J. 335: 691–696.
   PubMedGoogle Scholar
• Chai, Y., S. L. Koppenhafer, S. J. Shoesmith, M. K. Perez, and H. L. Paulson. 1999. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum. Mol. Genet. 8: 673–682.
   PubMed Web of Science ®Google Scholar
• Chan, J. Y., L. Li, Y. H. Fan, Z. M. Mu, W. W. Zhang, and K. S. Chang. 1997. Cell-cycle regulation of DNA damage-induced expression of the suppressor gene PML. Biochem. Biophys. Res. Commun. 240: 640–646.
   PubMed Web of Science ®Google Scholar
• Chelbi-Alix, M. K., L. Pelicano, F. Quignon, M. H. Koken, L. Venturini, M. Stadler, J. Pavlovic, L. Degos, and H. de The. 1995. Induction of the PML protein by interferons in normal and APL cells. Leukemia 9: 2027–2033.
   PubMedGoogle Scholar
• Cohen, N., M. Sharma, A. Kentsis, J. M. Perez, S. Strudwick, and K. L. B. Borden. 2001. PML RING suppresses oncogenic transformation by reducing the affinity of eIF4E for mRNA. EMBO J. 20: 4547–4559.
   PubMed Web of Science ®Google Scholar
• Desbois, C., R. Rousset, F. Bantignies, and P. Jalinot. 1996. Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-I Tax oncoprotein. Science 273: 951–953.
   PubMed Web of Science ®Google Scholar
• Djavani, M., J. Rodas, I. S. Lukashevich, D. Horejsh, P. P. Pandolfi, K. L. Borden, and M. S. Salvato. 2001. Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus. J. Virol. 75: 6204–6208.
   PubMedGoogle Scholar
• Doucas, V., M. Tini, D. A. Egan, and R. M. Evans. 1999. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. Proc. Natl. Acad. Sci. USA 96: 2627–2632.
   PubMedGoogle Scholar
• Duprez, E., A. J. Saurin, J. M. Desterro, V. Lallemand-Breitenbach, K. Howe, M. N. Boddy, E. Solomon, H. de The, R. T. Hay, and P. S. Freemont. 1999. SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localization. J. Cell Sci. 112: 381–393.
   PubMed Web of Science ®Google Scholar
• Dyck, J. A., G. G. Maul, W. H. Miller, Jr., J. D. Chen, A. Kakizuka, and R. M. Evans. 1994. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76: 333–343.
   PubMed Web of Science ®Google Scholar
• Everett, R. D. 2001. DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene 20: 7266–7273.
   PubMedGoogle Scholar
• Fagioli, M., M. Alcalay, P. P. Pandolfi, L. Venturini, A. Mencarelli, A. Simeone, D. Acampora, F. Grignani, and P. G. Pelicci. 1992. Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. Oncogene 7: 1083–1091.
   PubMedGoogle Scholar
• Ferbeyre, G., E. de Stanchina, E. Querido, N. Baptiste, C. Prives, and S. W. Lowe. 2000. PML is induced by oncogenic ras and promotes premature senescence. Genes Dev. 14: 2015–2027.
   PubMed Web of Science ®Google Scholar
• Ferrucci, P. F., F. Grignani, M. Pearson, M. Fagioli, I. Nicoletti, and P. G. Pelicci. 1997. Cell death induction by the acute promyelocytic leukemia-specific PML/RARalpha fusion protein. Proc. Natl. Acad. Sci. USA 94: 10901–10906.
   PubMed Web of Science ®Google Scholar
• Flenghi, L., M. Fagioli, L. Tomassoni, S. Pileri, M. Gambacorta, R. Pacini, F. Grignani, T. Casini, P. F. Ferrucci, M. F. Martelli, et al. 1995. Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia. Blood 85: 1871–1880.
   PubMed Web of Science ®Google Scholar
• Ford, L. P., Y. Zou, K. Pongracz, S. M. Gryaznov, J. W. Shay, and W. E. Wright. 2001. Telomerase can inhibit the recombination-based pathway of telomere maintenance in human cells. J. Biol. Chem. 276: 32198–32203.
   PubMed Web of Science ®Google Scholar
• Fu, X. D., and T. Maniatis. 1992. The 35-kDa mammalian splicing factor SC35 mediates specific interactions between U1 and U2 small nuclear ribonucleoprotein particles at the 3′ splice site. Proc. Natl. Acad. Sci. USA 89: 1725–1729.
   PubMedGoogle Scholar
• Gall, J. G. 2000. Cajal bodies: the first 100 years. Annu. Rev. Cell Dev. Biol. 16: 273–300.
   PubMed Web of Science ®Google Scholar
• Gharibyan, V., and H. Youssoufian. 1999. Localization of the Bloom syndrome helicase to punctate nuclear structures and the nuclear matrix and regulation during the cell cycle: comparison with the Werner's syndrome helicase. Mol. Carcinog. 26: 261–273.
   PubMedGoogle Scholar
• Gongora, C., G. David, L. Pintard, C. Tissot, T. D. Hua, A. Dejean, and N. Mechti. 1997. Molecular cloning of a new interferon-induced PML nuclear body-associated protein. J. Biol. Chem. 272: 19457–19463.
   PubMed Web of Science ®Google Scholar
• Grande, M. A., I. van der Kraan, B. van Steensel, W. Schul, H. de The, H. T. van der Voort, L. de Jong, and R. van Driel. 1996. PML-containing nuclear bodies: their spatial distribution in relation to other nuclear components. J. Cell. Biochem. 63: 280–291.
   PubMedGoogle Scholar
• Grimwade, D., and E. Solomon. 1997. Characterization of the PML/RARα rearrangement associated with t(15;17) acute promyelocytic leukaemia. Curr. Top. Microbiol. Immunol. 220: 81–112.
   PubMed Web of Science ®Google Scholar
• Grobelny, J. V., A. K. Godwin, and D. Broccoli. 2000. ALT-associated PML bodies are present in viable cells and are enriched in cells in the G2/M phase of the cell cycle J. Cell Sci. 113(Pt. 24): 4577–4585.
   PubMedGoogle Scholar
• Guiochon-Mantel, A., J. F. Savouret, F. Quignon, K. Delabre, E. Milgrom, and H. De The. 1995. Effect of PML and PML-RAR on the transactivation properties and subcellular distribution of steroid hormone receptors. Mol. Endocrinol. 9: 1791–1803.
   PubMedGoogle Scholar
• Hachiya, Y., K. Motonaga, M. Itoh, T. Masuko, T. Enomoto, H. Sonobe, and S. Takashima. 2001. Immunohistochemical expression and pathogenesis of BLM in the human brain and visceral organs. Neuropathology 21: 123–128.
   PubMedGoogle Scholar
• Hodges, M., C. Tissot, K. Howe, D. Grimwade, and P. S. Freemont. 1998. Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies. Am. J. Hum. Genet. 63: 297–304.
   PubMed Web of Science ®Google Scholar
• Iborra, F. J., D. A. Jackson, and P. R. Cook. 2001. Coupled transcription and translation within nuclei of mammalian cells. Science 293: 1139–1142.
   PubMed Web of Science ®Google Scholar
• Ishov, A. M., A. G. Sotnikov, D. Negorev, O. V. Vladimirova, N. Neff, T. Kamitani, E. T. Yeh, J. F. Strauss III, and G. G. Maul. 1999. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147: 221–234.
   PubMed Web of Science ®Google Scholar
• Jensen, K., C. Shiels, and P. S. Freemont. 2001. PML protein isoforms and the RBCC/TRIM motif. Oncogene 20: 7223–7233.
   PubMedGoogle Scholar
• Jepsen, K., O. Hermanson, T. M. Onami, A. S. Gleiberman, V. Lunyak, R. J. McEvilly, R. Kurokawa, V. Kumar, F. Liu, E. Seto, S. M. Hedrick, G. Mandel, C. K. Glass, D. W. Rose, and M. G. Rosenfeld. 2000. Combinatorial roles of the nuclear receptor corepressor in transcription and development. Cell 102: 753–763.
   PubMedGoogle Scholar
• Kastner, P., A. Perez, Y. Lutz, C. Rochette-Egly, M. P. Gaub, B. Durand, M. Lanotte, R. Berger, and P. Chambon. 1992. Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. EMBO J. 11: 629–642.
   PubMed Web of Science ®Google Scholar
• Kentsis, A., and K. L. B. Borden. 2000. Construction of macromolecular assemblages in eukaryotic processes and their role in human disease: linking RINGs together. Curr. Peptide Protein Sci. 1: 49–74.
   PubMedGoogle Scholar
• Kentsis, A., E. C. Dwyer, J. M. Perez, M. Sharma, A. Chen, Z. Q. Pan, and K. L. B. Borden. 2001. The RING domains of the promyelocytic leukemia protein PML and the arenaviral protein Z repress translation by directly inhibiting translation initiation factor eIF4E. J. Mol. Biol. 312: 609–623.
   PubMed Web of Science ®Google Scholar
• Kentsis, A., R. E. Gordon, and K. L. B. Borden. 2002. Self-assembly properties of a model RING domain. Proc. Natl. Acad. Sci. USA 99: 667–672.
   PubMed Web of Science ®Google Scholar
• Khan, M. M., T. Nomura, H. Kim, S. C. Kaul, R. Wadhwa, T. Shinagawa, E. Ichikawa-Iwata, S. Zhong, P. P. Pandolfi, and S. Ishii. 2001. Role of PML and PML-RARα in Mad-mediated transcriptional repression. Mol. Cell 7: 1233–1243.
   PubMedGoogle Scholar
• Lai, H. K., and K. L. Borden. 2000. The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA. Oncogene 19: 1623–1634.
   PubMed Web of Science ®Google Scholar
• Lallemand-Breitenbach, V., J. Zhu, F. Puvion, M. Koken, N. Honore, A. Doubeikovsky, E. Duprez, P. P. Pandolfi, E. Puvion, P. Freemont, and H. de The. 2001. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J. Exp. Med. 193: 1361–1371.
   PubMed Web of Science ®Google Scholar
• LaMorte, V. J., J. A. Dyck, R. L. Ochs, and R. M. Evans. 1998. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc. Natl. Acad. Sci. USA 95: 4991–4996.
   PubMedGoogle Scholar
• Lang, V., N. I. Zanchin, H. Lunsdorf, M. Tuite, and J. E. McCarthy. 1994. Initiation factor eIF-4E of Saccharomyces cerevisiae. Distribution within the cell, binding to mRNA, and consequences of its overproduction. J. Biol. Chem. 269: 6117–6123.
   PubMed Web of Science ®Google Scholar
• Lavau, C., A. Marchio, M. Fagioli, J. Jansen, B. Falini, P. Lebon, F. Grosveld, P. P. Pandolfi, P. G. Pelicci, and A. Dejean. 1995. The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene 11: 871–876.
   PubMed Web of Science ®Google Scholar
• Lazaris-Karatzas, A., M. R. Smith, R. M. Frederickson, M. L. Jaramillo, Y. L. Liu, H. F. Kung, and N. Sonenberg. 1992. Ras mediates translation initiation factor 4E-induced malignant transformation. Genes Dev. 6: 1631–1642.
   PubMed Web of Science ®Google Scholar
• Le, X. F., S. Vallian, Z. M. Mu, M. C. Hung, and K. S. Chang. 1998. Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis. Oncogene 16: 1839–1849.
   PubMedGoogle Scholar
• Le, X. F., P. Yang, and K. S. Chang. 1996. Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML. J. Biol. Chem. 271: 130–135.
   PubMed Web of Science ®Google Scholar
• Lejbkowicz, F., C. Goyer, A. Darveau, S. Neron, R. Lemieux, and N. Sonenberg. 1992. A fraction of the mRNA 5′ cap-binding protein, eukaryotic initiation factor 4E, localizes to the nucleus. Proc. Natl. Acad. Sci. USA 89: 9612–9616.
   PubMed Web of Science ®Google Scholar
• Maul, G. G., D. Negorev, P. Bell, and A. M. Ishov. 2000. Review: properties and assembly mechanisms of ND10, PML bodies, or PODs. J. Struct. Biol. 129: 278–287.
   PubMed Web of Science ®Google Scholar
• Maul, G. G., E. Yu, A. M. Ishov, and A. L. Epstein. 1995. Nuclear domain 10 (ND10) associated proteins are also present in nuclear bodies and redistribute to hundreds of nuclear sites after stress. J. Cell Biochem. 59: 498–513.
   PubMedGoogle Scholar
• McMahon, C., T. Suthiphongchai, J. DiRenzo, and M. E. Ewen. 1999. P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor. Proc. Natl. Acad. Sci. USA 96: 5382–5387.
   PubMed Web of Science ®Google Scholar
• Melchior, F. 2000. SUMO—nonclassical ubiquitin. Annu. Rev. Cell Dev. Biol. 16: 591–626.
   PubMed Web of Science ®Google Scholar
• Melnick, A., and J. D. Licht. 1999. Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93: 3167–3215.
   PubMed Web of Science ®Google Scholar
• Miller, S. J., T. Suthiphongchai, G. P. Zambetti, and M. E. Ewen. 2000. p53 binds selectively to the 5′-untranslated region of cdk4, an RNA element necessary and sufficient for transforming growth factor β- and p53-mediated translational inhibition of cdk4. Mol. Cell. Biol. 20: 8420–8431.
   PubMedGoogle Scholar
• Muratani, M., D. Gerlich, S. M. Janicki, M. Gebhard, R. Eils, and D. L. Spector. 2001. Metabolic-energy-dependent movement of PML bodies within the mammalian cell nucleus. Nat. Cell Biol. 21: 21.
   Google Scholar
• Nagy, E., and W. F. Rigby. 1995. Glyceraldehyde-3-phosphate dehydrogenase selectively binds AU-rich RNA in the NAD(+)-binding region (Rossmann fold). J. Biol. Chem. 270: 2755–2763.
   PubMed Web of Science ®Google Scholar
• Nayler, O., W. Stratling, J. P. Bourquin, I. Stagljar, L. Lindemann, H. Jasper, A. M. Hartmann, F. O. Fackelmayer, A. Ullrich, and S. Stamm. 1998. SAF-B protein couples transcription and pre-mRNA splicing to SAR/MAR elements. Nucleic Acids Res. 26: 3542–3549.
   PubMed Web of Science ®Google Scholar
• Newman, C. S., F. Chia, and P. A. Krieg. 1997. The XHex homeobox gene is expressed during development of the vascular endothelium: overexpression leads to an increase in vascular endothelial cell number. Mech. Dev. 66: 83–93.
   PubMedGoogle Scholar
• Nguyen, L. H., L. Espert, N. Mechti, and D. M. Wilson III. 2001. The human interferon- and estrogen-regulated ISG20/HEM45 gene product degrades single-stranded RNA and DNA in vitro. Biochemistry 40: 7174–7179.
   PubMed Web of Science ®Google Scholar
• Pearson, M., R. Carbone, C. Sebastiani, M. Cioce, M. Fagioli, S. Saito, Y. Higashimoto, E. Appella, S. Minucci, P. P. Pandolfi, and P. G. Pelicci. 2000. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406: 207–210.
   PubMed Web of Science ®Google Scholar
• Quignon, F., F. De Bels, M. Koken, J. Feunteun, J. C. Ameisen, and H. de The. 1998. PML induces a novel caspase-independent death process. Nat. Genet. 20: 259–265.
   PubMedGoogle Scholar
• Regad, T., and M. K. Chelbi-Alix. 2001. Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene 20: 7274–7286.
   PubMed Web of Science ®Google Scholar
• Regad, T., A. Saib, V. Lallemand-Breitenbach, P. P. Pandolfi, H. de The, and M. K. Chelbi-Alix. 2001. PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. EMBO J. 20: 3495–3505.
   PubMed Web of Science ®Google Scholar
• Reyes, J. C. 2001. PML and COP1—two proteins with much in common. Trends Biochem. Sci. 26: 18–20.
   PubMedGoogle Scholar
• Rogaia, D., F. Grignani, I. Nicoletti, and P. G. Pelicci. 1995. The acute promyelocytic leukemia-specific PML/RARα fusion protein reduces the frequency of commitment to apoptosis upon growth factor deprivation of GM-CSF-dependent myeloid cells. Leukemia 9: 1467–1472.
   PubMedGoogle Scholar
• Rosenwald, I. B., R. Kaspar, D. Rousseau, L. Gehrke, P. Leboulch, J. J. Chen, E. V. Schmidt, N. Sonenberg, and I. M. London. 1995. Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and post-transcriptional levels. J. Biol. Chem. 270: 21176–21180.
   PubMed Web of Science ®Google Scholar
• Rousseau, D., R. Kaspar, I. Rosenwald, L. Gehrke, and N. Sonenberg. 1996. Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E. Proc. Natl. Acad. Sci. USA 93: 1065–1070.
   PubMed Web of Science ®Google Scholar
• Roussel, M. J., and M. Lanotte. 2001. Maturation sensitive and resistant t(15;17) NB4 cell lines as tools for APL physiopathology: nomenclature of cells and repertory of their known genetic alterations and phenotypes. Oncogene 20: 7287–7291.
   PubMedGoogle Scholar
• Rubin, D. M., O. Coux, I. Wefes, C. Hengartner, R. A. Young, A. L. Goldberg, and D. Finley. 1996. Identification of the Gal4 suppressor Sug1 as a subunit of the yeast 26S proteasome. Nature 379: 655–657.
   PubMed Web of Science ®Google Scholar
• Sahlas, D. J., K. Milankov, P. C. Park, and U. De Boni. 1993. Distribution of snRNPs, splicing factor SC-35 and actin in interphase nuclei: immunocytochemical evidence for differential distribution during changes in functional states. J. Cell Sci. 105: 347–357.
   PubMedGoogle Scholar
• Schul, W., I. van Der Kraan, A. G. Matera, R. van Driel, and L. de Jong. 1999. Nuclear domains enriched in RNA 3′-processing factors associate with coiled bodies and histone genes in a cell cycle-dependent manner. Mol. Biol. Cell 10: 3815–3824.
   PubMedGoogle Scholar
• Seeler, J. S., and A. Dejean. 1999. The PML nuclear bodies: actors or extras? Curr. Opin. Genet. Dev. 9: 362–367.
   PubMedGoogle Scholar
• Shiels, C., S. A. Islam, R. Vatcheva, P. Sasieni, M. J. Sternberg, P. S. Freemont, and D. Sheer. 2001. PML bodies associate specifically with the MHC gene cluster in interphase nuclei. J. Cell Sci. 114: 3705–3716.
   PubMedGoogle Scholar
• Singh, R., and M. R. Green. 1993. Sequence-specific binding of transfer RNA by glyceraldehyde-3-phosphate dehydrogenase. Science 259: 365–368.
   PubMed Web of Science ®Google Scholar
• Skinner, P. J., B. T. Koshy, C. J. Cummings, I. A. Klement, K. Helin, A. Servadio, H. Y. Zoghbi, and H. T. Orr. 1997. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 389: 971–974.
   PubMed Web of Science ®Google Scholar
• Sonenberg, N., and A. C. Gingras. 1998. The mRNA 5′ cap-binding protein eIF4E and control of cell growth. Curr. Opin. Cell Biol. 10: 268–275.
   PubMed Web of Science ®Google Scholar
• Stadler, M., M. K. Chelbi-Alix, M. H. Koken, L. Venturini, C. Lee, A. Saib, F. Quignon, L. Pelicano, M. C. Guillemin, C. Schindler, et al. 1995. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene 11: 2565–2573.
   PubMed Web of Science ®Google Scholar
• Strudwick, S., and K. L. B. Borden. 2002. The emerging roles for nuclear translation factors. Differentiation 70: 10–22.
   PubMed Web of Science ®Google Scholar
• Stuurman, N., A. de Graaf, A. Floore, A. Josso, B. Humbel, L. de Jong, and R. van Driel. 1992. A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J. Cell Sci. 101: 773–784.
   PubMed Web of Science ®Google Scholar
• Terris, B., V. Baldin, S. Dubois, C. Degott, J. F. Flejou, D. Henin, and A. Dejean. 1995. PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res. 55: 1590–1597.
   PubMed Web of Science ®Google Scholar
• Topcu, Z., D. L. Mack, R. A. Hromas, and K. L. Borden. 1999. The promyelocytic leukemia protein PML interacts with the proline-rich homeodomain protein PRH: a RING may link hematopoiesis and growth control. Oncogene 18: 7091–7100.
   PubMedGoogle Scholar
• Topisirovic, I., A. D. Capili, and K. L. B. Borden. Gamma interferon and cadmium treatments modulate eukaryotic initiation factor 4E mRNA transport of cyclin D1 in a PML-dependent manner. Mol. Cell. Biol., in press.
   Google Scholar
• Tsukamoto, T., N. Hashiguchi, S. M. Janicki, T. Tumbar, A. S. Belmont, and D. L. Spector. 2000. Visualization of gene activity in living cells. Nat. Cell Biol. 2: 871–878.
   PubMed Web of Science ®Google Scholar
• Turelli, P., V. Doucas, E. Craig, B. Mangeat, N. Klages, R. Evans, G. Kalpana, and D. Trono. 2001. Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication. Mol. Cell 7: 1245–1254.
   PubMed Web of Science ®Google Scholar
• Turley, H., L. Wu, M. Canamero, K. C. Gatter, and I. D. Hickson. 2001. The distribution and expression of the Bloom's syndrome gene product in normal and neoplastic human cells. Br. J. Cancer 85: 261–265.
   PubMed Web of Science ®Google Scholar
• Vallian, S., J. A. Gaken, I. D. Trayner, E. B. Gingold, T. Kouzarides, K. S. Chang, and F. Farzaneh. 1997. Transcriptional repression by the promyelocytic leukemia protein, PML. Exp. Cell Res. 237: 371–382.
   PubMedGoogle Scholar
• Vareli, K., M. Frangou-Lazaridis, I. van der Kraan, O. Tsolas, and R. van Driel. 2000. Nuclear distribution of prothymosin alpha and parathymosin: evidence that prothymosin alpha is associated with RNA synthesis processing and parathymosin with early DNA replication. Exp. Cell Res. 257: 152–161.
   PubMedGoogle Scholar
• Wang, H., D. Kang, X. W. Deng, and N. Wei. 1999. Evidence for functional conservation of a mammalian homologue of the light-responsive plant protein COP1. Curr. Biol. 9: 711–714.
   PubMedGoogle Scholar
• Wang, X. W., A. Tseng, N. A. Ellis, E. A. Spillare, S. P. Linke, A. I. Robles, H. Seker, Q. Yang, P. Hu, S. Beresten, N. A. Bemmels, S. Garfield, and C. C. Harris. 2001. Functional interaction of p53 and BLM DNA helicase in apoptosis. J. Biol. Chem. 276: 32948–32955.
   PubMed Web of Science ®Google Scholar
• Wang, Z. G., L. Delva, M. Gaboli, R. Rivi, M. Giorgio, C. Cordon-Cardo, F. Grosveld, and P. P. Pandolfi. 1998. Role of PML in cell growth and the retinoic acid pathway. Science 279: 1547–1551.
   PubMed Web of Science ®Google Scholar
• Wang, Z. G., D. Ruggero, S. Ronchetti, S. Zhong, M. Gaboli, R. Rivi, and P. P. Pandolfi. 1998. PML is essential for multiple apoptotic pathways. Nat. Genet. 20: 266–272.
   PubMed Web of Science ®Google Scholar
• Weis, K., S. Rambaud, C. Lavau, J. Jansen, T. Carvalho, M. Carmo-Fonseca, A. Lamond, and A. Dejean. 1994. Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells. Cell 76: 345–356.
   PubMed Web of Science ®Google Scholar
• Wilkinson, M. F., and A. B. Shyu. 2001. Multifunctional regulatory proteins that control gene expression in both the nucleus and the cytoplasm. Bioessays 23: 775–787.
   PubMedGoogle Scholar
• Yankiwski, V., R. A. Marciniak, L. Guarente, and N. F. Neff. 2000. Nuclear structure in normal and Bloom syndrome cells. Proc. Natl. Acad. Sci. USA 97: 5214–5219.
   PubMed Web of Science ®Google Scholar
• Yankiwski, V., J. P. Noonan, and N. F. Neff. 2001. The C-terminal domain of the Bloom syndrome DNA helicase is essential for genomic stability. BMC Cell Biol. 2: 11.
   PubMedGoogle Scholar
• Yasuda, S., K. Inoue, M. Hirabayashi, H. Higashiyama, Y. Yamamoto, H. Fuyuhiro, O. Komure, F. Tanaka, G. Sobue, K. Tsuchiya, K. Hamada, H. Sasaki, K. Takeda, H. Ichijo, and A. Kakizuka. 1999. Triggering of neuronal cell death by accumulation of activated SEK1 on nuclear polyglutamine aggregations in PML bodies. Genes Cells 4: 743–756.
   PubMedGoogle Scholar
• Yeager, T. R., A. A. Neumann, A. Englezou, L. I. Huschtscha, J. R. Noble, and R. R. Reddel. 1999. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res. 59: 4175–4179.
   PubMed Web of Science ®Google Scholar